Multi-omic Liquid Biopsy Fingerstick Blood Test Platform for Neurological Disorders: Classification of Alzheimer’s Disease, Parkinson’s Disease and Myasthenia Gravis (P11-3.002)
To implement a multi-omic TempO-Seq® DBS test platform and specific tests for Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Myasthenia Gravis (gMG) using a fingerstick blood sample with the goal of improving diagnosis and reducing health disparities using samples that can be easily collected in a doctor’s office or self-collected.
Authors
- Bruce Seligmann (ORCID: https://orcid.org/0000-0002-1342-801X)
- Salvatore Camiolo (ORCID: https://orcid.org/0000-0002-8874-9993)
- Megan Opichka (ORCID: https://orcid.org/0000-0002-2961-8977)
- Joanne M. Yeakley (ORCID: https://orcid.org/0000-0002-8500-0442)
- Mónica Hernández Alava (ORCID: https://orcid.org/0000-0003-4474-5883)
- Gregory Sahagian
- Zhoutao Chen
Institutions
- Neurology Center of Southern California (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211881
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00